2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Colorectal Cancer in 2 studies
2,2-bis(4-glycidyloxyphenyl)propane: structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schaefer, KL | 1 |
| Takahashi, H | 1 |
| Morales, VM | 1 |
| Harris, G | 1 |
| Barton, S | 1 |
| Osawa, E | 1 |
| Nakajima, A | 1 |
| Saubermann, LJ | 1 |
| Fehlberg, S | 1 |
| Trautwein, S | 1 |
| Göke, A | 1 |
| Göke, R | 1 |
2 other studies available for 2,2-bis(4-glycidyloxyphenyl)propane and Colorectal Cancer
| Article | Year |
|---|---|
PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells.
Topics: Amino Acid Chloromethyl Ketones; Anilides; Animals; Apoptosis; Benzamides; Benzhydryl Compounds; Cac | 2007 |
Bisphenol A diglycidyl ether induces apoptosis in tumour cells independently of peroxisome proliferator-activated receptor-gamma, in caspase-dependent and -independent manners.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Benzhydryl Compounds; Carcinogens; Carcinoma; Caspases; Ce | 2002 |